Comparison of serum levels and clinical results of PUVA therapy with three different dosage forms of 8-methoxypsoralen.

作者信息

Siddiqui A H, Stolk L M, Cormane R H

出版信息

Arch Dermatol Res. 1984;276(5):343-5. doi: 10.1007/BF00404632.

DOI:10.1007/BF00404632

PMID:6486881

Abstract

摘要

相似文献

Comparison of serum levels and clinical results of PUVA therapy with three different dosage forms of 8-methoxypsoralen.

Arch Dermatol Res. 1984;276(5):343-5. doi: 10.1007/BF00404632.

Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis.

Arch Dermatol Res. 1982;273(3-4):219-23. doi: 10.1007/BF00409249.

Comparison of bioavailability and phototoxicity of two oral preparations of 5-methoxypsoralen.

Br J Dermatol. 1985 Apr;112(4):469-73. doi: 10.1111/j.1365-2133.1985.tb02322.x.

Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen.

Br J Dermatol. 1982 Feb;106(2):199-203. doi: 10.1111/j.1365-2133.1982.tb00929.x.

Photochemotherapy in psoriasis-clinical response and 8-MOP plasma concentrations at two dose levels.

Clin Exp Dermatol. 1981 Nov;6(6):591-600. doi: 10.1111/j.1365-2230.1981.tb02362.x.

Plasma 8-methoxypsoralen concentrations in photochemotherapy of psoriasis.

Br J Dermatol. 1981 Jan;104(1):47-51. doi: 10.1111/j.1365-2133.1981.tb01710.x.

[8-Methoxypsoralen (8-MOP)-a new galenic form and its relation to 8-MOP serum levels (author's transl)].

Arch Dermatol Res. 1981;271(1):11-7. doi: 10.1007/BF00417383.

Serum levels of 8-methoxypsoralen in two different drug preparations: correlation with photosensitivity and UV-A dose requirements for photochemotherapy.

J Invest Dermatol. 1982 Oct;79(4):233-6. doi: 10.1111/1523-1747.ep12500068.

Plasma levels of 8-methoxypsoralen after bath-PUVA for psoriasis: relationship to disease severity.

Br J Dermatol. 1995 Jul;133(1):37-40. doi: 10.1111/j.1365-2133.1995.tb02489.x.

Combination therapy of oral methoxypsoralen: photochemotherapy (PUVA) and an aromatic retinoid (etretinate, tigason) in the treatment of psoriasis.

J Dermatol. 1986 Apr;13(2):132-6. doi: 10.1111/j.1346-8138.1986.tb02913.x.

引用本文的文献

Inhibition of Caffeine Metabolism by and Families of Plant Products in Humans: and Studies.

Front Pharmacol. 2021 Apr 29;12:641090. doi: 10.3389/fphar.2021.641090. eCollection 2021.

Clinical pharmacokinetics of methoxsalen and other psoralens.

Clin Pharmacokinet. 1986 Jan-Feb;11(1):62-75. doi: 10.2165/00003088-198611010-00004.

本文引用的文献

Serum levels of 8-methoxypsoralen: difference between two oral methods of administration.

Br J Dermatol. 1980 Oct;103(4):417-20. doi: 10.1111/j.1365-2133.1980.tb07265.x.

[8-Methoxypsoralen (8-MOP)-a new galenic form and its relation to 8-MOP serum levels (author's transl)].

Arch Dermatol Res. 1981;271(1):11-7. doi: 10.1007/BF00417383.

Serum and saliva levels of 8-methoxypsoralen after rectal administration as a micro-enema.

Br J Dermatol. 1981 Apr;104(4):447-51. doi: 10.1111/j.1365-2133.1981.tb15316.x.

Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis.

Arch Dermatol Res. 1982;273(3-4):219-23. doi: 10.1007/BF00409249.

Serum levels of 8-methoxypsoralen in two different drug preparations: correlation with photosensitivity and UV-A dose requirements for photochemotherapy.

J Invest Dermatol. 1982 Oct;79(4):233-6. doi: 10.1111/1523-1747.ep12500068.

Initial photochemotherapy of psoriasis with orally administered 8-methoxypsoralen and longwave ultraviolet light (PUVA).

Br J Dermatol. 1979 Mar;100(3):247-50. doi: 10.1111/j.1365-2133.1979.tb06195.x.

Phototesting and dosimetry for photochemotherapy.

Br J Dermatol. 1977 Jan;96(1):1-10. doi: 10.1111/j.1365-2133.1977.tb05177.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验